La Jolla Pharmaceutical Company
LJPC
Price:
$6.19
Market Cap:
$0
La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic ...[Read more]
Industry
Biotechnology
IPO Date
1994-06-03
Stock Exchange
NASDAQ
Ticker
LJPC
PE Ratio
[47.62]
ROE
[-25.40%]
Current Ratio
[3.82]
Dividend Yield
[0%]
Enterprise Value
[-44025000.00]
Dividend History
The ROE as of December 2025 (TTM) for La Jolla Pharmaceutical Company (LJPC) is -25.40%
According to La Jolla Pharmaceutical Company’s latest financial reports and current stock price. The company's current ROE is -25.40%. This represents a change of 4.48% compared to the average of -0.55% of the last 4 quarters.
La Jolla Pharmaceutical Company (LJPC) Historical ROE (quarterly & annually)
How has LJPC ROE performed in the past?
The mean historical ROE of La Jolla Pharmaceutical Company over the last ten years is -114.29%. The current -25.40% ROE has changed -77.78% with respect to the historical average. Over the past ten years (40 quarters), LJPC's ROE was at its highest in in the June 2019 quarter at 241.53%. The ROE was at its lowest in in the March 2019 quarter at -280.37%.
Average
-114.29%
Median
-86.04%
Minimum
-555.30%
Maximum
208.09%
La Jolla Pharmaceutical Company (LJPC) ROE by Quarter and Year
Discovering the peaks and valleys of La Jolla Pharmaceutical Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 326.63%
Maximum Annual ROE = 208.09%
Minimum Annual Increase = -424.32%
Minimum Annual ROE = -555.30%
| Year | ROE | Change |
|---|---|---|
| 2021 | -29.46% | -165.83% |
| 2020 | 44.75% | -78.49% |
| 2019 | 208.09% | -137.47% |
| 2018 | -555.30% | 326.63% |
| 2017 | -130.16% | 1.61% |
| 2016 | -128.09% | 280.59% |
| 2015 | -33.66% | -23.48% |
| 2014 | -43.98% | -81.23% |
| 2013 | -234.35% | -2.65% |
| 2012 | -240.73% | -424.32% |
La Jolla Pharmaceutical Company (LJPC) Average ROE
How has LJPC ROE performed in the past?
The current ROE of La Jolla Pharmaceutical Company (LJPC) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
74.46%
5-year avg
-92.42%
10-year avg
-114.29%
La Jolla Pharmaceutical Company (LJPC) ROE vs. Peers
How is LJPC’s ROE compared to its peers?
La Jolla Pharmaceutical Company’s ROE is greater than F-star Therapeutics, Inc. (-44.74%), greater than eXoZymes, Inc. (-127.54%), less than Paratek Pharmaceuticals, Inc. (42.54%), greater than Pardes Biosciences, Inc. (-41.86%), less than Selecta Biosciences, Inc. (754.65%), greater than aTyr Pharma, Inc. (-100.11%), greater than NGM Biopharmaceuticals, Inc. (-69.76%), greater than Theseus Pharmaceuticals, Inc. (-20.74%), less than Sesen Bio, Inc. (86.43%), greater than LENZ Therapeutics, Inc. (-25.63%),
| Company | ROE | Market cap |
|---|---|---|
| -44.74% | $156.51M | |
| -127.54% | $124.05M | |
| 42.54% | $127.83M | |
| -41.86% | $135.19M | |
| 754.65% | $135.20M | |
| -100.11% | $75.47M | |
| -69.76% | $128.53M | |
| -20.74% | $181.50M | |
| 86.43% | $127.96M | |
| -25.63% | $506.30M |
Build a custom stock screener for La Jolla Pharmaceutical Company (LJPC) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like La Jolla Pharmaceutical Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
La Jolla Pharmaceutical Company (LJPC) and other stocks custom spreadsheet templates
The easiest way to analyze a company like La Jolla Pharmaceutical Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is La Jolla Pharmaceutical Company's ROE?
How is the ROE calculated for La Jolla Pharmaceutical Company (LJPC)?
What is the highest ROE for La Jolla Pharmaceutical Company (LJPC)?
What is the 3-year average ROE for La Jolla Pharmaceutical Company (LJPC)?
What is the 5-year average ROE for La Jolla Pharmaceutical Company (LJPC)?
How does the current ROE for La Jolla Pharmaceutical Company (LJPC) compare to its historical average?